Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy.
Tamori A, Kioka K, Sakaguchi H, Enomoto M, Hai H, Kawamura E, Hagihara A, Fujii H, Uchida-Kobayashi S, Iwai S, Morikawa H, Murakami Y, Kawasaki Y, Tsuruta D, Kawada N.
Tamori A, et al. Among authors: iwai s.
Ann Hepatol. 2015 Jan-Feb;14(1):28-35.
Ann Hepatol. 2015.
PMID: 25536639
Free article.
Clinical Trial.